Page 2 - Pascal Touchon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress

Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesPascal touchonPierre fabreProgram in nonCorporate communications investor relationsInternational society for cell gene therapyAtara biotherapeutics incSecurities exchangeProgram in lupus nephritisProgram in severe systemic lupus erythematosusExchange commissionChief executive officerPost transplant lymphoproliferative diseaseBiologics license applicationObjective response rateLupus nephritis

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPierre fabrePascal touchonDrug administrationExchange commissionAtara biotherapeutics incInternational society for cell gene therapySecurities exchangeCorporate communications investor relationsProgram in lupus nephritisProgram in nonNephritis studyEnrolling with initial clinical data expectedRunway intoKey pipelineChief executive officer

Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy

Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesRajani dinavahiPascal touchonDrug administrationExchange commissionAtara biotherapeutics incSecurities exchangeInvestigational new drugChief executive officerChief medical officerSecurities actSecurities exchange actMiddle eastSouthern californiaFinancial conditionRefractory systemic autoimmune diseases

ATARA Biotherapeutics (ATRA) Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219

ATARA Biotherapeutics (ATRA) Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rajani dinavahiPascal touchonDrug administrationAtara biotherapeutics incInvestigational new drugChief executive officerChief medical officer

Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy

Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPascal touchonRajani dinavahiAtara biotherapeutics incDrug administrationCorporate communications investor relationsSecurities exchangeExchange commissionAutoimmune diseaseClinical dataLupus nephritisInvestigational new drugChief executive officerChief medical officerSecurities actSecurities exchange act